BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31935332)

  • 1. An update on the Cartwright (Yt) blood group system.
    George MR
    Immunohematology; 2019 Dec; 35(4):154-155. PubMed ID: 31935332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of anti-Yta antibody in a Yt(a+) patient.
    Mazzi G; Raineri A; Santarossa L; De Roia D; Orazi BM
    Vox Sang; 1994; 66(2):130-2. PubMed ID: 8184594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase.
    Spring FA; Gardner B; Anstee DJ
    Blood; 1992 Oct; 80(8):2136-41. PubMed ID: 1391965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype.
    Rao N; Whitsett CF; Oxendine SM; Telen MJ
    Blood; 1993 Feb; 81(3):815-9. PubMed ID: 8427972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YTGT: A new high-prevalence antigen in the Yt blood group system in two unrelated Native Americans and transfusion management.
    Van Buren NL; Gillen B; Lomas-Francis C; Burgos A; Pease D; Beaver M; Imbryk A; Dugger J; Fugate A; Hebel E; Lodermeier M; Vege S; Westhoff CM
    Transfusion; 2022 Sep; 62(9):1917-1922. PubMed ID: 35904131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfusion policy toward a patient with an anti-Cartwright antibody (anti-Yta)].
    Arriaga F; García R; Guinot M; de la Rubia J; García M; Bonanad S; Marty ML
    Sangre (Barc); 1993 Aug; 38(4):327-9. PubMed ID: 8235948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].
    Franchini M; Fabbian F; Piccoli PL; Gandini G; Aprili G; Loschiavo C; Lupo A
    G Ital Nefrol; 2004; 21(4):387-90. PubMed ID: 15526404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid in vivo destruction of Yt(a+) erythrocytes in a recipient with anti-Yta.
    Ballas SK; Sherwood WC
    Transfusion; 1977; 17(1):65-6. PubMed ID: 841677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic and IgG subclass characterization of Cartwright (Yt) and Gerbich (Ge) antibodies.
    Vengelen-Tyler V; Morel PA
    Transfusion; 1983; 23(2):114-6. PubMed ID: 6836689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with anti-Cartwright (Yta).
    Mohandas K; Spivack M; Delehanty CL
    Transfusion; 1985; 25(4):381-4. PubMed ID: 4024238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The red cell antigens A, B, D, U, Ge, Jk3 and Yta are not detected on human granulocytes.
    Gaidulis L; Branch DR; Lazar GS; Petz LD; Blume KG
    Br J Haematol; 1985 Aug; 60(4):659-68. PubMed ID: 3927971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity.
    Branch DR; Muensch HA; Sy Siok Hian AL; Petz LD
    Br J Haematol; 1983 Aug; 54(4):573-8. PubMed ID: 6871108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Yt blood groups in Israeli Jews, Arabs, and Druse.
    Levene C; Bar-Shany S; Manny N; Moulds JJ; Cohen T
    Transfusion; 1987; 27(6):471-4. PubMed ID: 3686656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-aminoethylisothiouronium-treated red cells and the Cartwright (Yta) antigen.
    Levene C; Harel N
    Transfusion; 1984; 24(6):541. PubMed ID: 6506190
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of anti-Yta antibodies using a sensitive and specific enzyme-linked immunosorbent assay.
    Geen J; Hullin DA; Hogg SI
    Br J Biomed Sci; 1999; 56(2):128-33. PubMed ID: 10695054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta.
    Davey RJ; Simpkins SS
    Transfusion; 1981; 21(6):702-5. PubMed ID: 7314218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Yt blood group system (ISBT No. 011). Genetic studies.
    Lewis M; Kaita H; Philipps S; McAlpine PJ; Wong P; Giblett ER; Anderson J
    Vox Sang; 1987; 53(1):52-6. PubMed ID: 3477904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assignment of the YT blood group locus to chromosome 7q.
    Zelinski T; White L; Coghlan G; Philipps S
    Genomics; 1991 Sep; 11(1):165-7. PubMed ID: 1765374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Normal survival in vivo of Yt (a+) red blood cells in a patient with anti-Yta].
    Serrano J; Paniagua C; Sánchez Fayos J; Outeiriño J; Calabuig T; Escudero A
    Sangre (Barc); 1986; 31(6):768-71. PubMed ID: 3563836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.